Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00085397 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: autologous dendritic cell-tumor fusion vaccine
BIOLOGICAL: gp100 antigen
BIOLOGICAL: therapeutic autologous dendritic cells

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]